相似文献
1
Understanding obesity and endometrial cancer risk: opportunities for prevention.
Am J Obstet Gynecol. 2011 Dec;205(6):518-25. doi: 10.1016/j.ajog.2011.05.042. Epub 2011 Jun 7.
2
Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden).
Cancer Causes Control. 2000 Feb;11(2):185-92. doi: 10.1023/a:1008946825313.
3
Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.
J Clin Oncol. 2016 Dec 10;34(35):4225-4230. doi: 10.1200/JCO.2016.69.4638. Epub 2016 Nov 7.
4
The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
Gynecol Oncol. 2019 Jun;153(3):580-588. doi: 10.1016/j.ygyno.2019.03.102. Epub 2019 Mar 29.
5
Identifying High-Risk Women for Endometrial Cancer Prevention Strategies: Proposal of an Endometrial Cancer Risk Prediction Model.
Cancer Prev Res (Phila). 2017 Jan;10(1):1-13. doi: 10.1158/1940-6207.CAPR-16-0224. Epub 2016 Dec 13.
6
Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women.
Am J Epidemiol. 2005 May 15;161(10):939-47. doi: 10.1093/aje/kwi127.
7
Endometrial Cancer: Is This a New Disease?
Am Soc Clin Oncol Educ Book. 2017;37:435-442. doi: 10.1200/EDBK_175666.
8
Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship.
Gynecol Oncol. 2009 Jul;114(1):121-7. doi: 10.1016/j.ygyno.2009.03.039. Epub 2009 Apr 29.
9
Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors.
Am J Epidemiol. 2008 Mar 1;167(5):607-14. doi: 10.1093/aje/kwm333. Epub 2007 Dec 10.
10
Obesity and Endometrial Cancer.
Recent Results Cancer Res. 2016;208:107-136. doi: 10.1007/978-3-319-42542-9_7.
引用本文的文献
1
Tamoxifen induces PI3K activation in uterine cancer.
Nat Genet. 2025 Aug 22. doi: 10.1038/s41588-025-02308-w.
2
Association of dietary inflammatory index with gynecological cancers in NHANES 2011-2018.
Front Nutr. 2025 May 12;12:1560987. doi: 10.3389/fnut.2025.1560987. eCollection 2025.
3
Therapeutic Potential of Anti-Diabetes Drugs and Anti-Dyslipidemia Drugs to Mitigate Head and Neck Cancer Risk in Metabolic Syndrome.
CNS Neurosci Ther. 2025 May;31(5):e70446. doi: 10.1111/cns.70446.
4
Prenatally androgenized PCOS mice have ovary-independent uterine dysfunction and placental inflammation aggravated by high-fat diet.
Sci Adv. 2025 May 9;11(19):eadu3699. doi: 10.1126/sciadv.adu3699.
5
Feasibility of Measuring Context Specific Sedentary Behavior and Pulse Wave Velocity in Endometrial Cancer Survivors.
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251324912. doi: 10.1177/15347354251324912. Epub 2025 Mar 12.
6
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study.
Gynecol Oncol. 2025 Apr;195:66-74. doi: 10.1016/j.ygyno.2025.03.003. Epub 2025 Mar 8.
7
Epigenetic mechanisms underlying endometrial cancer outcomes: race-specific patterns of DNA methylation associated with molecular subtypes and survival.
Carcinogenesis. 2025 Jan 20;46(1). doi: 10.1093/carcin/bgaf004.
8
Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications.
Front Med. 2024 Dec;18(6):945-968. doi: 10.1007/s11684-024-1094-2. Epub 2024 Nov 14.
9
Trends of endometrial cancer incidence in Sri Lanka from 2011 to 2020: An analysis of annual national cancer incidence data reports.
J Family Med Prim Care. 2024 Aug;13(8):3304-3308. doi: 10.4103/jfmpc.jfmpc_1990_23. Epub 2024 Jul 26.
10
Comprehensive Evaluation of a Levonorgestrel Intrauterine Device (LNG-IUD), Metformin, and Liraglutide for Fertility Preservation in Endometrial Cancer: Protocol for a Randomized Clinical Trial.
Life (Basel). 2024 Jun 29;14(7):835. doi: 10.3390/life14070835.
本文引用的文献
1
Metabolic surgery and cancer: protective effects of bariatric procedures.
Cancer. 2011 May 1;117(9):1788-99. doi: 10.1002/cncr.25738. Epub 2010 Nov 29.
2
A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):971-7. doi: 10.1158/1055-9965.EPI-10-1222. Epub 2011 Mar 17.
3
Relationship of resistin levels with endometrial cancer risk.
Neoplasma. 2011;58(2):124-8. doi: 10.4149/neo_2011_02_124.
4
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.
Nat Rev Endocrinol. 2011 Apr;7(4):219-31. doi: 10.1038/nrendo.2010.217. Epub 2011 Jan 25.
5
The association of body mass index with mortality in the California Teachers Study.
Int J Cancer. 2011 Nov 15;129(10):2492-501. doi: 10.1002/ijc.25905. Epub 2011 Apr 8.
6
Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
J Steroid Biochem Mol Biol. 2011 Sep;126(3-5):113-20. doi: 10.1016/j.jsbmb.2010.12.006. Epub 2010 Dec 17.
7
Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis.
Am J Clin Nutr. 2011 Feb;93(2):234-42. doi: 10.3945/ajcn.110.002683. Epub 2010 Dec 8.
8
Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.
Cancer Causes Control. 2010 Dec;21(12):2303-8. doi: 10.1007/s10552-010-9658-7. Epub 2010 Oct 17.
9
Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.
Endocr Relat Cancer. 2010 Oct 29;17(4):1007-19. doi: 10.1677/ERC-10-0053. Print 2010 Dec.
10
Chemoprevention meets glucose control.
Cancer Prev Res (Phila). 2010 Sep;3(9):1049-52. doi: 10.1158/1940-6207.CAPR-10-0178. Epub 2010 Sep 1.
Zotero 插件